Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...

Novo Nordisk expands collaboration with Valo Health for cardiometabolic drugs and partners with Variant Bio on metabolic ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The deal extends an agreement to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...

Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care ...

A new study reveals that junk food and drug use are hindering life expectancy gains in the U.S., despite technological ...

Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...

These high-carb foods can enhance your athletic performance and recovery, help you gain weight, boost your metabolism, and ...

Drugs for metabolic diseases, vaccines and cancer therapies feature among new product launches this year that could top $1 billion in annual sales or be clinical "game changers" in the next five years ...